Beyond the storm - subacute toxicities and late effects in children receiving CAR T cells.

Abstract

As clinical advances with chimeric antigen receptor (CAR) T cells are increasingly described and the potential for extending their therapeutic benefit grows, optimizing the implementation of this therapeutic modality is imperative. The recognition and management of cytokine release syndrome (CRS) marked a milestone in this field; however, beyond the understanding gained in treating CRS, a host of additional toxicities and/or potential late effects of CAR T cell therapy warrant further investigation. A multicentre initiative involving experts in paediatric cell therapy, supportive care and/or study of late effects from cancer and haematopoietic stem cell transplantation was convened to facilitate the comprehensive study of extended CAR T cell-mediated toxicities and establish a framework for new systematic investigations of CAR T cell-related adverse events. Together, this group identified six key focus areas: extended monitoring of neurotoxicity and neurocognitive function, psychosocial considerations, infection and immune reconstitution, other end organ toxicities, evaluation of subsequent neoplasms, and strategies to optimize remission durability. Herein, we present the current understanding, gaps in knowledge and future directions of research addressing these CAR T cell-related outcomes. This systematic framework to study extended toxicities and optimization strategies will facilitate the translation of acquired experience and knowledge for optimal application of CAR T cell therapies.

• Authors: Haneen Shalabi, Juliane Gust, Agne Taraseviciute, Pamela L Wolters, Allison B Leahy, Carlos Sandi, Theodore W Laetsch, Lori Wiener, Rebecca A Gardner, Veronique Nussenblatt, Joshua A Hill, Kevin J Curran, Timothy S Olson, Colleen Annesley, Hao-Wei Wang, Javed Khan, Marcelo C Pasquini, Christine N Duncan, Stephan A Grupp, Michael A Pulsipher, Nirali N Shah
• Journal: Nature reviews. Clinical oncology (Nat Rev Clin Oncol) Vol. 18 Issue 6 Pg. 363-378 (06 2021) ISSN: 1759-4782 [Electronic] England
• PMID: 33495553 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, N.I.H., Intramural, Research Support, Non-U.S. Gov't, Review)

Chemical References

• Biomarkers
• Receptors, Chimeric Antigen

Topics

• Biomarkers (blood)
• Child
• Cytokine Release Syndrome (etiology)
• Humans
• Immunotherapy, Adoptive (adverse effects)
• Infections (etiology)
• Neoplasms (psychology, therapy)
• Neuroimaging (methods)
• Neurotoxicity Syndromes (diagnostic imaging, etiology)
• Receptors, Chimeric Antigen